The clinical efficacy of intramuscular artemether was studied in 144 c
hildren suffering from severe non cerebral malaria. Fifty-three childr
en with chloroquine-resistant and 27 children with sulfadoxine-pyrimet
hamine-resistant falciparum malaria were also studied. Greater than 95
% of pre-treatment parasitaemia was cleared by 24 h after commencement
of treatment in all groups. The parasite and fever clearance times we
re 35.4 +/- 8.0 and 18.6 +/- 6.3 h, respectively, in children sufferin
g from severe non cerebral malaria, 36.3 +/- 7.9 and 15.6 +/- 3.8 h, r
espectively, in the chloroquine-resistant and 36.8 +/- 8.8 and 16.5 +/
- 4.2 h, respectively, in the sulfadoxine-pyrimethamine-resistant grou
ps. The cure rate in all groups on day 14 was 100%. Side effects follo
wing treatment were minimal and comprised pain with mild tenderness at
site of injection in two children and bradycardia, on the second or t
hird day of treatment, in another two patients. No patient had pruritu
s. These data suggest that artemether is rapidly effective in falcipar
um malaria in children irrespective of previous drug treatment and esp
ecially in chloroquine- or sulphadoxine-pyrimethamine-resistant infect
ion and in this study was without deleterious side effects.